A contemporary review with meta-analysis demonstrated that exercise-based cardiac rehabilitation (ExCR) appears beneficial and safe for patients with atrial fibrillation (AF). The study analyzed data from 20 randomized clinical trials involving 2,039 participants with a mean follow-up of 11 months. ExCR did not significantly affect all-cause mortality (8.3% vs 6.0%; rate ratio [RR] 1.06) or serious adverse events (2.9% vs 4.1%; RR 1.30), but it significantly improved several clinical outcomes: reduced AF symptom severity, AF burden, episode frequency and duration, and AF recurrence (RR 0.68), while also enhancing exercise capacity (VO2 peak mean difference 3.18 mL/kg/min). Mental, but not physical, components of health-related quality of life improved. The effects of ExCR were consistent across trials. No differences were observed across AF subtypes, ExCR dosage, or delivery methods. ExCR has shown improvements in functional capacity and quality of life in other cardiac conditions, such as heart failure and coronary artery disease. Source: https://bjsm.bmj.com/content/
A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…
Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…
A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…
Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…
A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…
Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…
This website uses cookies.